Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar

Adeel A. Butt; Mylai D. Guerrero; Elenor B. Canlas; Husni Al-Dwairi; Abeir Bakhiet Mohammed Ali Alimam; Abdur Rehman Mohamad; Mohammed Thamer Ali; Nidal Ahmad Asaad; Ali Ahmed Sheikh Saleh Alkeldi; Mohammad Fawaz Saber Mohammad; Anil G. Thomas; Abdullatif Al-Khal; Muna Al-Maslamani; Abdul-Badi Abou-Samra

doi:10.1038/s41467-022-35653-z

Nature Communications (Jan 2023)

Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar

Adeel A. Butt,
Mylai D. Guerrero,
Elenor B. Canlas,
Husni Al-Dwairi,
Abeir Bakhiet Mohammed Ali Alimam,
Abdur Rehman Mohamad,
Mohammed Thamer Ali,
Nidal Ahmad Asaad,
Ali Ahmed Sheikh Saleh Alkeldi,
Mohammad Fawaz Saber Mohammad,
Anil G. Thomas,
Abdullatif Al-Khal,
Muna Al-Maslamani,
Abdul-Badi Abou-Samra

Affiliations

Adeel A. Butt: Corporate Quality and Patient Safety Department, Hamad Medical Corporation
Mylai D. Guerrero: Corporate Quality and Patient Safety Department, Hamad Medical Corporation
Elenor B. Canlas: Corporate Quality and Patient Safety Department, Hamad Medical Corporation
Husni Al-Dwairi: Corporate Quality and Patient Safety Department, Hamad Medical Corporation
Abeir Bakhiet Mohammed Ali Alimam: Communicable Diseases Center, Hamad Medical Corporation
Abdur Rehman Mohamad: Communicable Diseases Center, Hamad Medical Corporation
Mohammed Thamer Ali: Heart Hospital, Hamad Medical Corporation
Nidal Ahmad Asaad: Heart Hospital, Hamad Medical Corporation
Ali Ahmed Sheikh Saleh Alkeldi: Corporate Quality and Patient Safety Department, Hamad Medical Corporation
Mohammad Fawaz Saber Mohammad: Corporate Quality and Patient Safety Department, Hamad Medical Corporation
Anil G. Thomas: Corporate Quality and Patient Safety Department, Hamad Medical Corporation
Abdullatif Al-Khal: Communicable Diseases Center, Hamad Medical Corporation
Muna Al-Maslamani: Communicable Diseases Center, Hamad Medical Corporation
Abdul-Badi Abou-Samra: Corporate Quality and Patient Safety Department, Hamad Medical Corporation

DOI: https://doi.org/10.1038/s41467-022-35653-z
Journal volume & issue: Vol. 14, no. 1
pp. 1 – 5

Abstract

Read online

This study assesses the probability that deaths following a COVID-19 vaccination are attributable to the vaccine. The authors review all deaths that occurred within 30 days of vaccine receipt in Qatar until June 2022 and find that deaths attributable to vaccination are extremely rare.

Published in Nature Communications

ISSN: 2041-1723 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Science
Website: https://www.nature.com/ncomms/

About the journal